Renew your commitment to a community centered around you. Join us as we work to overcome the challenges of today and work toward a better tomorrow. Enroll in auto-renewal of your ACC membership when ...

A one-time infusion of an investigational CRISPR-Cas9 therapy targeting angiopoietin-like protein 3 (ANGPTL3) was safe and reduced LDL cholesterol by nearly 50% and reduced triglycerides by ...

We are a young, vibrant section dedicated to adding value to Section members interested in Innovation across the cardiovascular spectrum. Our section is member-driven and focused on all aspects of ...

Patients with obstructive hypertrophic cardiomyopathy (oHCM) treated with aficamten saw superior benefits in heart failure symptoms, exercise capacity, left ventricular outflow tract (LVOT) gradient ...

New late-breaking science presented at AHA 2025 in New Orleans highlights new treatments for patients with severe hypertriglyceridemia (500-2,000 mg/dL), who may be at high risk of cardiovascular ...

The Centers for Medicare and Medicaid Services (CMS) has issued the 2026 Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center (ASC) Payment System final rule. CMS has ...

Marijuana is now legal in many places, but is it safe? Two new studies add to mounting evidence that people who use cannabis are more likely to suffer a heart attack than people who do not use the ...

Fewer than half of young adults with severely high low-density lipoprotein (LDL-C), or “bad” cholesterol, levels start taking a statin within five years of first high LDL-C measurement, according to a ...

Get coverage of important new developments in cardiology ...

This page features ACC's full coverage of the latest science from American Heart Association's (AHA) Scientific Sessions 2025, taking place Nov. 7–10 in New Orleans, LA.

Learn more about the advertising opportunities with Cardiology magazine, ACC's member magazine.